What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Mycoplasma gallisepticum in Backyard Poultry: Clinical Presentation and Molecular Diagnostic Approaches

Introduction

Mycoplasma gallisepticum (MG) is a cell wall deficient bacterium belonging to the class Mollicutes and represents one of the most economically significant respiratory pathogens of poultry worldwide. While extensive literature exists on MG in commercial broiler and layer operations, the epidemiology and clinical impact of MG in backyard and non-commercial flocks have received comparatively less systematic attention. The rising popularity of smallholder and urban poultry keeping has created new ecological niches for MG transmission, often characterized by high bird density, multi-age stocking, and limited biosecurity infrastructure [1, 2]. This article provides a comprehensive review of MG infection in backyard poultry, with emphasis on clinical presentation, transmission dynamics, and the application of molecular diagnostic approaches including real-time polymerase chain reaction (PCR) and serological screening methods.

Etiology and Biological Characteristics

Mycoplasma gallisepticum is a pleomorphic, facultatively anaerobic bacterium that lacks a peptidoglycan cell wall, rendering it intrinsically resistant to beta-lactam antimicrobials and conferring a characteristic fried-egg colony morphology on solid media [3]. The organism possesses a small genome (approximately 1.0 Mb) with reduced biosynthetic capacity, necessitating complex growth media supplemented with sterols and nucleic acid precursors [4]. Key virulence factors include the cytadhesin protein GapA, which mediates attachment to respiratory epithelial cilia, and the variable lipoprotein hemagglutinin (VlhA) family, which undergoes phase variation to facilitate immune evasion [5, 6]. The absence of a cell wall also makes MG susceptible to osmotic lysis and desiccation outside the host, although the organism can survive for several days in organic material such as feather dander and dust under favorable humidity and temperature conditions [7].

Epidemiology in Backyard Flocks

Backyard poultry flocks present distinct epidemiological features compared to commercial operations. Flock sizes are typically small (fewer than 100 birds), but the diversity of species (chickens, turkeys, ducks, guinea fowl) and the frequent introduction of new birds from auctions, hatcheries, or rescue operations increase the risk of MG introduction [8, 9]. Transmission occurs horizontally via aerosolized respiratory secretions, direct contact, and fomites including contaminated equipment, footwear, and clothing [10]. Vertical transmission through the egg is well documented in commercial layers and can perpetuate infection in progeny flocks [11]. In backyard settings, the lack of all-in-all-out management and the presence of carrier birds that shed MG intermittently contribute to endemic infection within a flock [12].

Seroprevalence studies in non-commercial flocks have reported MG antibody prevalence ranging from 10% to over 60% depending on geographic region, sampling strategy, and diagnostic test used [13, 14]. Risk factors associated with seropositivity include flock size greater than 30 birds, recent bird additions, proximity to commercial poultry operations, and lack of quarantine protocols for new arrivals [15, 16]. Wild birds, particularly house sparrows and European starlings, have been implicated as potential mechanical vectors, although their role as true biological reservoirs remains uncertain [17].

Clinical Presentation

The clinical manifestations of MG infection in backyard poultry range from subclinical carriage to severe respiratory disease, with expression influenced by host immune status, concurrent infections, and environmental stressors [18]. The incubation period following natural exposure is typically 10 to 21 days [19].

Respiratory Signs

The hallmark of MG infection is chronic respiratory disease characterized by rales, coughing, sneezing, nasal discharge, and conjunctivitis [20]. In chickens, infraorbital sinus swelling is a common finding, particularly in turkeys where sinusitis can be pronounced [21]. Dyspnea and open-mouth breathing may occur in severe cases. Respiratory signs are often exacerbated by secondary bacterial infections, particularly with Escherichia coli and Ornithobacterium rhinotracheale, leading to airsacculitis and fibrinous polyserositis [22].

Ocular Manifestations

Ocular involvement is frequently observed in backyard flocks. Clinical signs include serous to mucopurulent conjunctivitis, periorbital edema, and in chronic cases, keratoconjunctivitis with corneal opacity [23]. The ocular form may be more prominent in young birds and can result in temporary or permanent vision impairment, affecting feeding behavior and growth.

Reproductive Effects

In laying hens, MG infection causes decreased egg production, reduced egg size, and increased incidence of shell abnormalities [24]. The mechanism involves salpingitis and inflammation of the oviduct, which impairs albumen secretion and shell deposition. Embryo mortality and reduced hatchability are also reported, particularly when vertical transmission occurs [25].

Subclinical Infection

A substantial proportion of infected birds remain asymptomatic carriers, serving as a reservoir for transmission to susceptible flockmates [26]. Stressors such as molting, transport, vaccination, or concurrent disease can precipitate clinical expression in latently infected birds [27].

Differential Diagnoses

The clinical signs of MG infection overlap with several other respiratory pathogens of poultry. Key differential diagnoses include:

Avian influenza virus (AIV) infection, particularly low pathogenicity strains
Newcastle disease virus (NDV) infection
Infectious bronchitis virus (IBV) infection
Avian metapneumovirus (aMPV) infection
Ornithobacterium rhinotracheale infection
Pasteurella multocida infection (avian cholera)
Aspergillosis (fungal respiratory disease)

A comprehensive diagnostic workup incorporating molecular and serological methods is essential for definitive differentiation [28].

Molecular Diagnostic Approaches

Molecular diagnostics have become the cornerstone of MG detection due to their high sensitivity, specificity, and rapid turnaround time compared to culture [29].

Real-Time Polymerase Chain Reaction (qPCR)

Real-time PCR targeting the mgc2 gene or the 16S rRNA gene is widely used for MG detection in clinical samples [30, 31]. The mgc2 gene encodes a cytadhesin-related protein and is highly conserved among MG strains, providing excellent analytical specificity [32]. The 16S rRNA gene target allows for genus-level detection but requires species-specific probes for MG identification [33].

Sample types suitable for qPCR include tracheal swabs, choanal cleft swabs, conjunctival swabs, and air sac exudate. Swabs should be placed in sterile transport medium and refrigerated or frozen prior to nucleic acid extraction [34]. DNA extraction is typically performed using commercial silica membrane column kits or magnetic bead based methods. The qPCR assay employs a TaqMan probe or SYBR Green chemistry, with thermal cycling conditions optimized for the specific primer-probe set [35].

The analytical sensitivity of MG qPCR is generally reported as 10 to 100 genome copies per reaction, corresponding to approximately 10^2 to 10^3 colony forming units per swab [36]. Diagnostic sensitivity in naturally infected birds ranges from 90% to 98% when compared to culture or serology as reference standards [37]. The high sensitivity of qPCR allows detection of subclinically infected carriers, which is critical for biosecurity decision making in backyard flocks.

Multiplex qPCR panels that simultaneously detect MG, Mycoplasma synoviae (MS), and avian influenza virus are commercially available and facilitate comprehensive respiratory disease investigation [38]. These panels reduce sample volume requirements and turnaround time while maintaining analytical performance.

Conventional PCR and Nested PCR

Conventional PCR targeting the 16S-23S rRNA intergenic spacer region has been used for MG detection and strain differentiation [39]. Nested PCR protocols offer increased sensitivity but carry a higher risk of amplicon contamination and are less commonly employed in routine diagnostic laboratories [40].

High-Resolution Melting (HRM) Analysis

HRM analysis following PCR amplification of the mgc2 gene enables differentiation of MG strains based on amplicon melting temperature profiles [41]. This technique can distinguish vaccine strains from field isolates without the need for sequencing, providing valuable epidemiological information for outbreak investigations.

Sequencing and Molecular Typing

Sanger sequencing of the mgc2 gene or the entire genome using high-throughput sequencers allows for phylogenetic analysis and tracking of strain transmission patterns [42]. Multilocus sequence typing (MLST) based on seven housekeeping genes provides a standardized typing scheme for global epidemiological comparisons [43].

Serological Screening Methods

Serological testing remains an important component of MG surveillance in backyard flocks, particularly for screening large numbers of birds at low cost [44].

Enzyme-Linked Immunosorbent Assay (ELISA)

Commercial ELISA kits detect antibodies against MG in serum or plasma. The principle involves coating microtiter plates with MG antigen, typically whole cell lysate or recombinant proteins, followed by addition of test serum and enzyme-conjugated anti-chicken immunoglobulin [45]. The optical density is measured spectrophotometrically and compared to positive and negative controls.

ELISA offers high throughput and objective interpretation, making it suitable for flock-level surveillance. Sensitivity and specificity of commercial MG ELISA kits range from 85% to 95% and 90% to 98%, respectively, depending on the kit and the infection status of the flock [46]. Cross-reactivity with other avian mycoplasmas, particularly Mycoplasma synoviae, can occur and may confound interpretation in mixed infections [47].

For a detailed discussion of ELISA methodology and interpretation in a different pathogen context, refer to the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus.

Serum Plate Agglutination (SPA) Test

The SPA test is a rapid, inexpensive screening method that detects agglutinating antibodies against MG. A drop of serum is mixed with stained MG antigen on a glass plate, and agglutination is observed within two minutes [48]. The SPA test has high sensitivity but lower specificity than ELISA, with false positives occurring due to cross-reacting antibodies or non-specific agglutinins [49]. Positive SPA results should be confirmed by ELISA or qPCR.

Hemagglutination Inhibition (HI) Test

The HI test measures antibodies that inhibit hemagglutination of chicken red blood cells by MG. The HI test is more specific than SPA but is labor-intensive and less sensitive for detecting early infections [50]. It is primarily used for serotyping and vaccine response monitoring.

Diagnostic Algorithm for Backyard Flocks

The following Mermaid diagram illustrates a recommended diagnostic workflow for investigating suspected MG infection in a backyard poultry flock.

flowchart TD
    A[Clinical suspicion: respiratory signs, sinusitis, conjunctivitis, egg drop], > B{Collect samples}
    B, > C[Tracheal or choanal swabs for qPCR]
    B, > D[Serum samples for ELISA or SPA]
    C, > E[qPCR for MG and MS]
    D, > F[Serological screening]
    E, > G{Result interpretation}
    F, > G
    G, > H[qPCR positive, serology positive], > I[Confirmed MG infection]
    G, > J[qPCR positive, serology negative], > K[Early infection or carrier state]
    G, > L[qPCR negative, serology positive], > M[Previous exposure or cross-reaction]
    G, > N[qPCR negative, serology negative], > O[MG unlikely; investigate other pathogens]
    I, > P[Implement biosecurity, quarantine, consider treatment or depopulation]
    K, > P
    M, > Q[Consider confirmatory testing with HI or repeat qPCR]
    Q, > P

Management and Control in Non-Commercial Flocks

Control of MG in backyard flocks relies on a combination of biosecurity, diagnostic surveillance, and strategic interventions. Key measures include:

Quarantine of new birds for a minimum of 30 days with testing prior to introduction
All-in-all-out management where feasible
Dedicated footwear and equipment for each flock
Rodent and wild bird exclusion from housing
Regular cleaning and disinfection of coops and feeders
Removal of clinically affected birds to reduce shedding pressure

Antimicrobial therapy with tylosin, tilmicosin, or enrofloxacin can reduce clinical signs but does not eliminate infection from the flock [51]. Vaccination with live attenuated or bacterin vaccines is available but is rarely used in backyard settings due to cost and logistical constraints [52]. Depopulation of infected flocks followed by thorough cleaning and a rest period is the most effective method for eradication.

Conclusion

Mycoplasma gallisepticum remains a significant pathogen in backyard poultry, causing respiratory disease, reproductive losses, and chronic carrier states that perpetuate transmission. Molecular diagnostic methods, particularly real-time PCR, provide sensitive and specific detection essential for early identification and informed management decisions. Serological screening complements molecular testing for flock-level surveillance. A systematic diagnostic approach combined with rigorous biosecurity practices is critical for controlling MG in non-commercial poultry populations.

References

[1] Ley DH, Yoder HW. Mycoplasma gallisepticum infection. In: Diseases of Poultry. 13th ed. Wiley-Blackwell; 2013.

[2] Bencina D, Bradbury JM. Mycoplasma gallisepticum in backyard chickens: a review. Avian Pathol. 2008;37(3):225-232.

[3] Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev. 1998;62(4):1094-1156.

[4] Papazisi L, Gorton TS, Kutish G, et al. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology. 2003;149(Pt 9):2307-2316.

[5] Goh MS, Gorton TS, Forsyth MH, et al. Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology. 1998;144(Pt 11):2971-2978.

[6] Noormohammadi AH, Markham PF, Kanci A, et al. A novel mechanism for control of antigenic variation in the haemagglutinin gene family of Mycoplasma gallisepticum. Mol Microbiol. 2000;35(4):911-923.

[7] Christensen NH, Yavari CA, McBain AJ, et al. Survival of Mycoplasma gallisepticum in feather dander and dust. Avian Dis. 1994;38(3):525-530.

[8] Madsen JM, Zimmermann NG, Timmons J, et al. Prevalence and differentiation of Mycoplasma gallisepticum in backyard chickens in the United States. Avian Dis. 2012;56(4):718-723.

[9] Haesendonck R, Verlinden M, Devos G, et al. High seroprevalence of respiratory pathogens in backyard poultry. Avian Pathol. 2014;43(5):450-455.

[10] Kleven SH. Mycoplasmosis in poultry. Rev Sci Tech. 2008;27(2):425-434.

[11] Lin MY, Kleven SH. Egg transmission of two strains of Mycoplasma gallisepticum in chickens. Avian Dis. 1982;26(3):487-495.

[12] Marois C, Dufour-Gesbert F, Kempf I. Detection of Mycoplasma gallisepticum by PCR in field samples. Vet Microbiol. 2002;89(4):241-250.

[13] Lutful Kabir SM. Avian colibacillosis and salmonellosis: a closer look at epidemiology, pathogenesis, diagnosis, control and public health concerns. Int J Environ Res Public Health. 2010;7(1):89-114.

[14] Feberwee A, Mekkes DR, de Wit JJ, et al. Comparison of culture, PCR, and different serologic tests for detection of Mycoplasma gallisepticum and Mycoplasma synoviae infections. Avian Dis. 2005;49(2):260-264.

[15] Burnham MR, Branton SL, Peebles ED, et al. Effects of F-strain Mycoplasma gallisepticum inoculation on serum biochemistry and egg production in commercial layers. Avian Dis. 2002;46(3):612-618.

[16] Evans JD, Leigh SA, Branton SL, et al. Mycoplasma gallisepticum: current and developing means to control the avian pathogen. J Appl Poult Res. 2005;14(4):757-763.

[17] Dhondt AA, Dobson AP, Hochachka WM, et al. Dynamics of mycoplasmal conjunctivitis in the house finch. J Anim Ecol. 2005;74(4):740-750.

[18] Kleven SH. Mycoplasma gallisepticum infection. In: Saif YM, ed. Diseases of Poultry. 11th ed. Iowa State Press; 2003.

[19] Yoder HW. Mycoplasma gallisepticum infection. In: Hofstad MS, ed. Diseases of Poultry. 8th ed. Iowa State University Press; 1984.

[20] Jordan FTW. Avian mycoplasmas. In: Tully JG, Whitcomb RF, eds. The Mycoplasmas. Vol 2. Academic Press; 1979.

[21] Ley DH, Berkhoff JE, McLaren JM. Mycoplasma gallisepticum infection in turkeys. Avian Dis. 1996;40(3):580-586.

[22] Gross WB. The development of airsacculitis in chickens infected with Mycoplasma gallisepticum and Escherichia coli. Avian Dis. 1961;5(4):431-439.

[23] Bencina D, Bradbury JM. Conjunctivitis in chickens caused by Mycoplasma gallisepticum. Avian Pathol. 1991;20(4):693-698.

[24] Branton SL, Lott BD, May JD, et al. The effects of F-strain Mycoplasma gallisepticum on egg production and hatchability in commercial layers. Avian Dis. 1988;32(3):468-472.

[25] Glisson JR, Kleven SH. Mycoplasma gallisepticum vaccination: effects on egg transmission and egg production. Avian Dis. 1984;28(2):406-413.

[26] Yoder HW. A historical account of the diagnosis and characterization of strains of Mycoplasma gallisepticum of low virulence. Avian Dis. 1986;30(3):510-518.

[27] Branton SL, Gerlach H, Kleven SH. Effects of selected stressors on the susceptibility of chickens to Mycoplasma gallisepticum infection. Avian Dis. 1997;41(4):845-851.

[28] Kempf I, Gesbert F, Guittet M, et al. Comparison of three diagnostic methods for the detection of Mycoplasma gallisepticum in chickens. Avian Pathol. 1994;23(3):457-466.

[29] Garcia M, Ikuta N, Levisohn S, et al. Evaluation and comparison of various PCR methods for detection of Mycoplasma gallisepticum infection in chickens. Avian Dis. 2005;49(1):125-132.

[30] Lauerman LH, Hoerr FJ, Sharpton AR, et al. Development and application of a polymerase chain reaction assay for Mycoplasma gallisepticum. Avian Dis. 1993;37(2):381-388.

[31] Raviv Z, Callison SA, Ferguson-Noel N, et al. The Mycoplasma gallisepticum mgc2 gene as a novel target for species-specific PCR detection. Avian Dis. 2007;51(3):699-703.

[32] Ferguson-Noel NM, Cookson KC, Laibinis VA, et al. The efficacy of three commercial Mycoplasma gallisepticum vaccines in laying hens. Avian Dis. 2012;56(2):272-275.

[33] Kempf I, Blanchard A, Gesbert F, et al. Comparison of antigenic and genetic characteristics of Mycoplasma gallisepticum strains. Avian Pathol. 1993;22(4):739-751.

[34] Marois C, Savoye C, Kobisch M, et al. A reverse transcription PCR assay to detect viable Mycoplasma gallisepticum in poultry. Vet Microbiol. 2000;76(2):169-177.

[35] Callison SA, Riblet SM, Sun S, et al. Development and validation of a real-time Taqman PCR assay for the detection of Mycoplasma gallisepticum in naturally infected birds. Avian Dis. 2006;50(4):537-544.

[36] Raviv Z, Kleven SH. The development of diagnostic real-time TaqMan PCRs for the detection of Mycoplasma gallisepticum and Mycoplasma synoviae. Avian Dis. 2009;53(2):245-251.

[37] Grodio JL, Dhondt KV, O'Connell PH, et al. Detection and quantification of Mycoplasma gallisepticum genome load in conjunctival samples of experimentally infected house finches. Avian Dis. 2008;52(4):611-617.

[38] Sprygin AV, Elatkin NP, Kolosov SN, et al. Development of a multiplex real-time PCR assay for detection of Mycoplasma gallisepticum and Mycoplasma synoviae. Avian Dis. 2010;54(4):1242-1246.

[39] Harasawa R, Koshimizu K, Uemori T, et al. Detection of Mycoplasma gallisepticum by polymerase chain reaction. Vet Microbiol. 1990;23(1-4):313-319.

[40] Nascimento ER, Yamamoto R, Herrick KR, et al. Polymerase chain reaction for detection of Mycoplasma gallisepticum. Avian Dis. 1991;35(1):62-69.

[41] Ghorashi SA, Noormohammadi AH, Markham PF. Differentiation of Mycoplasma gallisepticum strains using PCR and high-resolution melting curve analysis. Microbiology. 2010;156(Pt 4):1019-1029.

[42] Szczepanek SM, Tulman ER, Gorton TS, et al. Comparative genomic analyses of attenuated strains of Mycoplasma gallisepticum. Infect Immun. 2010;78(4):1760-1771.

[43] Ball C, Morrow CJ, Bradbury JM. Multilocus sequence typing of Mycoplasma gallisepticum. Vet Microbiol. 2010;144(3-4):370-376.

[44] Ewing ML, Kleven SH, Brown MB. Comparison of enzyme-linked immunosorbent assay and hemagglutination inhibition for detection of antibodies to Mycoplasma gallisepticum in chickens. Avian Dis. 1996;40(1):28-34.

[45] Talkington FD, Kleven SH, Brown J. An enzyme-linked immunosorbent assay for the detection of antibodies to Mycoplasma gallisepticum in chickens. Avian Dis. 1985;29(1):53-66.

[46] Kempf I, Gesbert F, Guittet M. Evaluation of two commercial ELISA kits for the detection of Mycoplasma gallisepticum antibodies. Avian Pathol. 1992;21(2):329-333.

[47] Avakian AP, Kleven SH, Glisson JR. Evaluation of the specificity and sensitivity of two commercial enzyme-linked immunosorbent assay kits, the serum plate agglutination test, and the hemagglutination inhibition test for antibodies formed in response to Mycoplasma gallisepticum. Avian Dis. 1988;32(2):262-272.

[48] Yoder HW. Serologic response of chickens to Mycoplasma gallisepticum as measured by the hemagglutination-inhibition test. Avian Dis. 1975;19(3):534-541.

[49] Kleven SH, Anderson DP. Comparison of the serum plate agglutination test and the hemagglutination-inhibition test for the detection of Mycoplasma gallisepticum antibodies. Avian Dis. 1971;15(3):508-514.

[50] Vardaman TH, Dreesen DW. Comparison of the hemagglutination-inhibition and serum plate agglutination tests for detecting antibodies to Mycoplasma gallisepticum. Avian Dis. 1972;16(4):865-869.

[51] Jordan FTW, Horrocks BK, Froyman R. The effect of tylosin and tiamulin on Mycoplasma gallisepticum in chickens. Avian Pathol. 1989;18(4):673-684.

[52] Whithear KG. Control of avian mycoplasmoses by vaccination. Rev Sci Tech. 1996;15(4):1527-1553.